TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/26/2026
Back to search
Official data from USPTO
MYRISK HEREDITARY CANCER TEST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
05/29/2026
Trademark type
Combined
Nice classes
10
Filing date
01/17/2025
Registration date
06/10/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/10/2025
Last transaction
05/29/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
11/05/2021
First use in commerce
11/05/2021
Drawing code
3
Owner type
03
Owner location
Salt Lake City, UT, US
Examiner
SWAIN, MICHELE LYNN
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a three-dimensional configuration of a box. The side of the box is light blue and features the wording “MYRISK” in large white stylized letters, stacked above the wording “Hereditary Cancer Test” in smaller white letters. The matter shown in broken lines in the drawing is not part of the mark, but merely shows the orientation and placement of the mark when used.
Holders and representatives
Holders
Myriad Genetics, Inc.
Representatives
Joyce M. Ferraro Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical test kits comprising specimen collection tubes and containers for collecting patient specimens along with printed test formsmailing materialsprinted user information inserts for use in detection of gene mutationsgene expression profiles or other molecular indicators or markers associated with disease or risk of developing disease.
Publications
History of USPTO decisions and trademark events.
22 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/26/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/26/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/26/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/26/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/10/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
06/10/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/22/2025
PUBO
PUBLISHED FOR OPPOSITION
04/22/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/16/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/27/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/26/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/26/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/26/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/13/2025
GNRT
NON-FINAL ACTION E-MAILED
02/13/2025
CNRT
NON-FINAL ACTION WRITTEN
02/13/2025
DOCK
ASSIGNED TO EXAMINER
02/07/2025
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/06/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/06/2025
MAFR
APPLICATION FILING RECEIPT MAILED
01/17/2025
NWAP
NEW APPLICATION ENTERED
01/17/2025
Continuous trademark protection
Get notified about every new filing that threatens MYRISK HEREDITARY CANCER TEST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.